Hydroxocobalamin vs Methylcobalamin: Which B12 Form Is Actually Best?

← Back to articles

Vitamin B12 comes in four forms used in supplements: cyanocobalamin (the cheap, stable, lab-made form), hydroxocobalamin (the form bacteria actually make), and the two coenzyme forms the body uses in cells — methylcobalamin and adenosylcobalamin. Marketing has built up the idea that “active” methylcobalamin is the only correct choice. The clinical evidence is more mixed than that.

How the body handles each form

All four forms are absorbed through the intrinsic-factor pathway. At very high oral doses, about 1% of the dose also crosses the gut wall by simple diffusion, which is why 1,000 µg pills work even in pernicious anemia. Once inside cells, the body converts B12 between the methyl and adenosyl coenzyme forms as needed. Cyanocobalamin must first have its cyanide group removed, a small extra step that is fine in healthy adults but can be slower in heavy smokers, since the cyanide-detox system is already busy with cigarette smoke.

Hydroxocobalamin: the underrated workhorse

Hydroxocobalamin is the standard B12 injection in much of Europe. It binds plasma proteins more tightly than cyanocobalamin and is cleared from the body more slowly, so injections can be spaced further apart. It is the gold-standard injection for pernicious anemia and is also approved as an antidote for cyanide poisoning. Oral hydroxocobalamin is less common in the US but is clinically interchangeable with methylcobalamin for most everyday supplementation.

When methylcobalamin specifically helps

For diabetic peripheral neuropathy, several randomized trials and meta-analyses have tested high-dose methylcobalamin (typically 1,500–5,000 µg/day) and reported small improvements in nerve-conduction tests and pain scores compared with placebo or cyanocobalamin. The effect size is modest and the trial quality is mixed (Sun 2018, Diabetes Research and Clinical Practice; PMID 29626491). For ordinary B12 deficiency, all four forms work; making sure you absorb and store enough B12 matters more than which form you pick.

MTHFR and the “methyl” debate

MTHFR gene variants affect folate metabolism, not B12 metabolism. The popular advice that MTHFR carriers must use methylcobalamin is not strongly supported. What does help MTHFR-variant individuals is using methylfolate (5-MTHF) instead of synthetic folic acid. The B12 form choice is secondary.

Practical recommendation

For routine supplementation, any of the four forms at 500–1,000 µg/day is enough. For documented deficiency, methyl- or hydroxocobalamin at 1,000–2,000 µg/day is reasonable. For diabetic neuropathy, high-dose methylcobalamin has slightly better evidence. Do not lose sleep over the choice — B12 form selection is one of the lower-stakes decisions in supplementation.